The data indicated that in 86.7% (117/135) of the CRC patients, hypermethylation of BEND5 was at least 2-fold higher in the tumor tissues than in the matched normal colorectal tissues (Table 1, Supplementary Figure 1). This evidence concerns the gene BEND5 and colorectal carcinoma.